Clinical Trial Update: Retaane® in Age-Related Macular Degeneration [Phase 2, Phase 3]

View source ↗

Summary

Retaane has completed Phase 2 and Phase 3 trials for age-related macular degeneration, according to a ClinicalTrials.gov update. The status is listed as COMPLET…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Retaane

Snippet

Sponsor: Rudolf Foundation Clinic | Conditions: Age Related Macular Degeneration | Phase 2, Phase 3 | Status: COMPLETED